MedTrace Logo

Definitive (Chemo)Radiotherapy for Patients With Esophageal Cancer - 3JECROG R-01

NCT03298204 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2762

Last updated 2019-01-02

No results posted yet for this study

Summary

The aim of this observational study is to retrospectively collect survival data for 3000 primary esophageal cancer patients from multicenter between January 2000 to present. Based on a Cox model, we want to develope a nomogram that predicts local recurrence, distant metastases, and survival for patients treated with radiotherapy or chemoradiotherapy with or without chemotherapy.

Conditions

  • Esophagus Cancer
  • Chemoradiation
  • Chemotherapy Effect
  • Radiotherapy Side Effect

Sponsors & Collaborators

  • Hebei Medical University Fourth Hospital

    collaborator OTHER

  • Fujian Cancer Hospital

    collaborator OTHER_GOV

  • Anyang Tumor Hospital

    collaborator OTHER

  • The First Affiliated Hospital with Nanjing Medical University

    collaborator OTHER

  • Affiliated Hospital of Hebei University

    collaborator OTHER

  • Tianjin Medical University Cancer Institute and Hospital

    collaborator OTHER

  • Beijing Hospital

    collaborator OTHER_GOV

  • Tengzhou Central People's Hospital

    collaborator OTHER_GOV

  • PLA Army General Hospital

    collaborator UNKNOWN

  • Chinese Academy of Medical Sciences

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-06-01
Primary Completion
2017-09-30
Completion
2018-02-28

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03298204 on ClinicalTrials.gov